trial · primary record
mRNA-1283
SARS-CoV-2
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2029-08-30 |
| Primary endpoint | Cohort 1 and Cohort 2: Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs) |
| Registry ID | NCT07808697 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:46.953Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07808697
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.